Vanda Pharmaceuticals Receives Revised Unsolicited Acquisition Proposal From Future Pak For $8.50-$9.00 Per Share In Cash Plus Contingent Value Rights; No Shareholder Action Required At This Time
Vanda Pharmaceuticals Receives Revised Unsolicited Acquisition Proposal From Future Pak For $8.50-$9.00 Per Share In Cash Plus Contingent Value Rights; No Shareholder Action Required At This Time
萬達生物製藥收到未經請求的修訂收購建議書，未來派提出每股8.50-9.00美元的現金加有條件的價值權，並且此刻不需要股東採取任何行動。
Vanda Pharmaceuticals Receives Revised Unsolicited Acquisition Proposal From Future Pak For $8.50-$9.00 Per Share In Cash Plus Contingent Value Rights; No Shareholder Action Required At This Time
萬達生物製藥收到未經請求的修訂收購建議書，未來派提出每股8.50-9.00美元的現金加有條件的價值權，並且此刻不需要股東採取任何行動。
譯文內容由第三人軟體翻譯。
以上內容僅用作資訊或教育之目的，不構成與富途相關的任何投資建議。富途竭力但無法保證上述全部內容的真實性、準確性和原創性。